Evaluation of efficacy and safety profiles of tribulus terristrus in males with partial androgen deficiency and erectile dysfunction and lower urinary tract symptoms in a placebo controlled study

Evaluation of efficacy and safety profiles of tribulus terristrus in males with partial androgen deficiency and erectile dysfunction and lower urinary tract symptoms in a placebo controlled study - Safety and efficacy of tribulus terristrus in PADAM patients with erectile dysfunction and LUTS in a placebo controlled study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000023070

Enrollment

Registered

2016-07-08

Start date

2017-06-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

partial androgen deficiency with erectile dysfunction and low libido

Interventions

one group of the PADAM patients will recieve placebo 3 times daily for 3 months with follow up of PSA / liver enzymes/ testosterone/ international prostate symptoms score (IPSS)/ validated Arabic vers

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: PADAM patients with erectile dysfunction and lower urinary tract symptoms

Exclusion criteria

Exclusion criteria: 1)PADAM patients without erectile dysfunction and low libido 2)PADAM patients with major systemic illness, smoking, drug addict, alcohol abuse

Design outcomes

Primary

Measure	Time frame
Not yet available as the study is pre-intiating	—

Secondary

Measure	Time frame
Not yet available as the study is pre-intiating	—

Countries

Africa

Contacts

Public ContactSameh Fayek

Cairo University Andrology department

samehfayek@kasralainy.edu.cu.eg01227109309

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026